Literature DB >> 751721

A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment.

F Cavalli, L Tschopp, R W Sonntag, A Zimmermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 751721

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  10 in total

1.  The small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin.

Authors:  Jiajiu Shaw; Joseph Media; Ben Chen; Fredrick Valeriote
Journal:  Cancer Chemother Pharmacol       Date:  2013-07-24       Impact factor: 3.333

2.  In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach.

Authors:  Young-Eun Cho; Thoudam S K Singh; Hyun-Chul Lee; Pyong-Gon Moon; Jeong-Eun Lee; Myung-Hoon Lee; Eung-Chil Choi; Yu-Ju Chen; Sang-Hyun Kim; Moon-Chang Baek
Journal:  Mol Cell Proteomics       Date:  2011-10-24       Impact factor: 5.911

Review 3.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

4.  Genome-wide Association Study on Platinum-induced Hepatotoxicity in Non-Small Cell Lung Cancer Patients.

Authors:  Songyu Cao; Cheng Wang; Hongxia Ma; Rong Yin; Meng Zhu; Wei Shen; Juncheng Dai; Yongqian Shu; Lin Xu; Zhibin Hu; Hongbing Shen
Journal:  Sci Rep       Date:  2015-06-23       Impact factor: 4.379

5.  Amelioration of cisplatin-induced nephrotoxicity by statins.

Authors:  Rajesh A Maheshwari; Girish U Sailor; Lalji Patel; R Balaraman
Journal:  Indian J Pharmacol       Date:  2013 Jul-Aug       Impact factor: 1.200

6.  Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer.

Authors:  A Muscella; C Vetrugno; D Migoni; F Biagioni; F P Fanizzi; F Fornai; S A De Pascali; S Marsigliante
Journal:  Cell Death Dis       Date:  2014-01-23       Impact factor: 8.469

7.  Protective effects of pine bark extract against cisplatin-induced hepatotoxicity and oxidative stress in rats.

Authors:  Je-Won Ko; In-Chul Lee; Sung-Hyuk Park; Changjong Moon; Seong-Soo Kang; Sung-Ho Kim; Jong-Choon Kim
Journal:  Lab Anim Res       Date:  2014-12-24

8.  Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity.

Authors:  Joseph L Jilek; Kayla L Frost; Kevyn A Jacobus; Wenxi He; Erica L Toth; Michael Goedken; Nathan J Cherrington
Journal:  Acta Pharm Sin B       Date:  2021-06-02       Impact factor: 11.413

9.  Platinum-based drug-induced depletion of amino acids in the kidneys and liver.

Authors:  Katerina Mitrevska; Natalia Cernei; Hana Michalkova; Migue Angel Merlos Rodrigo; Ladislav Sivak; Zbynek Heger; Ondrej Zitka; Pavel Kopel; Vojtech Adam; Vedran Milosavljevic
Journal:  Front Oncol       Date:  2022-09-21       Impact factor: 5.738

10.  Targeted Delivery of Cisplatin-Derived Nanoprecursors via a Biomimetic Yeast Microcapsule for Tumor Therapy by the Oral Route.

Authors:  Xing Zhou; Kaijian Ling; Mengyu Liu; Xiangjun Zhang; Jun Ding; Yan Dong; Zhiqing Liang; Jianjun Li; Jianxiang Zhang
Journal:  Theranostics       Date:  2019-08-21       Impact factor: 11.556
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.